Delivery Order SPE2DB22D3016-SPE2DB25FBDH1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY transdermal patches (three-patch supply) under a firm fixed-price contract valued at $1,214.87. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery against an existing contract vehicle. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. XULANE is a contraceptive...
- The Defense Logistics Agency awarded a delivery order valued at $3,276.00 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price, non-set-aside delivery order was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Xulane is a combination hormonal contraceptive patch used for birth control and is...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.20 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (quantity: 3) with a firm fixed price structure. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.78 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $4,418.88 to supply Xulane 150-35 mcg/day transdermal patches (quantity: 3 units). This is a firm fixed price delivery order with no set-aside designation, completed competitively under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order is set to be fulfilled by the ultimate completion date of August 13, 2025, with the place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $2,042.60 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/day contraceptive patches (quantity of 3 units) on August 8, 2025, with a completion date of August 11, 2025. This firm fixed-price, competitively awarded delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (three-count unit) on August 5, 2025. This firm fixed price, non-set-aside delivery order is positioned for ultimate completion by August 6, 2025, with performance executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $2,481.92 delivery order to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day patches (three-unit package) under a firm fixed-price contract. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,040.92 to AmerisourceBergen Drug Corp for Xulane 150-35 microgram/day transdermal patches (three-count packaging). This firm fixed-price, non-set-aside contract was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $1,677.50 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XULANE 150-35 MCG/DAY contraceptive patches in support of military treatment programs and facilities. This order is issued under an existing $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the prime contractor, which serves as the primary vehicle for...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDH1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,127.12 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day patches (3-count) on July 28, 2025, with a completion date of July 29, 2025. This firm fixed price, competitively awarded delivery order represents a routine pharmaceutical supply transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and no set-aside designation was used for this procurement. XULANE is a transdermal contraceptive patch used within military and federal healthcare systems to support medical supply needs across the Defense Health Agency and other government entities. This delivery order exemplifies the routine pharmaceutical fulfillment that occurs under AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The contract award demonstrates the company's ongoing capability to meet federal medical procurement requirements through open competition and flexible delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/28/25 |